Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 117,828 | 112,567 | 80,618 | 122,715 | 175,761 |
| Marketable Securities | 83,256 | 72,425 | 106,876 | 67,893 | 24,963 |
| Receivables | 3,041 | 24,650 | 7,424 | 12,660 | 11,159 |
| Inventories | 25,583 | 23,958 | 23,425 | 21,599 | 14,621 |
| Other current assets | 0 | 0 | 0 | 7,656 | 0 |
| TOTAL | $256,109 | $246,040 | $231,500 | $243,060 | $241,815 |
| Non-Current Assets | |||||
| PPE Net | 918 | 1,136 | 1,393 | 1,658 | 1,995 |
| Intangibles | 17,500 | 17,750 | 18,000 | 18,250 | 18,500 |
| Other Non-Current Assets | 208,536 | 219,406 | 191,969 | 196,704 | 197,643 |
| TOTAL | $226,954 | $238,292 | $211,362 | $216,612 | $218,138 |
| Total Assets | $483,063 | $484,332 | $442,862 | $459,672 | $459,953 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,012 | 648 | 1,391 | 7,899 | 1,469 |
| Accrued Expenses | 41,149 | 35,316 | 20,885 | 30,112 | 30,868 |
| Other current liabilities | 6,430 | 4,596 | 4,334 | 5,754 | 8,789 |
| TOTAL | $53,468 | $47,472 | $36,587 | $47,066 | $56,492 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,564 | 4,674 | 6,495 | N/A | 12,092 |
| Other Non-Current Liabilities | 12,596 | 13,198 | 4,017 | 4,457 | 5,255 |
| TOTAL | $24,468 | $25,204 | $16,180 | $16,457 | $19,453 |
| Total Liabilities | $77,936 | $72,676 | $52,767 | $63,523 | $75,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,338 | 70,168 | 69,900 | 69,753 | 69,532 |
| Common Shares | 20 | 19 | 19 | 19 | 19 |
| Retained earnings | -503,187 | -489,332 | -504,304 | -492,034 | -496,495 |
| Other shareholders' equity | -1 | 13 | 55 | 44 | -70 |
| TOTAL | $405,127 | $411,656 | $390,095 | $396,149 | $384,008 |
| Total Liabilities And Equity | $483,063 | $484,332 | $442,862 | $459,672 | $459,953 |